WallStreetZenWallStreetZen

NASDAQ: STAA
Staar Surgical Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for STAA

Based on 7 analysts offering 12 month price targets for Staar Surgical Co

Min Forecast
$19.00-22.58%
Avg Forecast
$28.86+17.59%
Max Forecast
$37.00+50.77%

Should I buy or sell STAA stock?

Based on 7 analysts offering ratings for Staar Surgical Co.

Buy
Strong Buy
3 analysts 42.86%
Buy
1 analysts 14.29%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
1 analysts 14.29%
Although STAA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates STAA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their STAA stock forecasts and price targets.

STAA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-29
lockedlocked$00.00+00.00%2026-09-22
lockedlocked$00.00+00.00%2026-08-13
lockedlocked$00.00+00.00%2026-08-13
lockedlocked$00.00+00.00%2026-05-15
Canaccord Genuity
Bottom 25%
25
Strong BuyMaintains$32.00+30.40%2026-05-14
Piper Sandler
Top 23%
78
HoldMaintains$33.00+34.47%2026-05-14
Mizuho
Top 5%
96
HoldMaintains$27.00+10.02%2026-05-14

1 of 1

Forecast return on equity

Is STAA forecast to generate an efficient return?

Company
18.9%
Industry
25.21%
Market
172.15%
STAA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STAA forecast to generate an efficient return on assets?

Company
14.53%
Industry
17.98%
STAA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STAA earnings per share forecast

What is STAA's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$0.28+251.38%
Avg 2 year Forecast
$0.56+604.13%
Avg 3 year Forecast
$0.67+739.88%
STAA's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

STAA revenue forecast

What is STAA's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$341.0M+0.41%
Avg 2 year Forecast
$370.7M+9.16%
Avg 3 year Forecast
$401.2M+18.13%
STAA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STAA earnings growth forecast

How is STAA forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
106.6%
Industry
28.51%
Market
32.54%
STAA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
STAA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
STAA's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

STAA revenue growth forecast

How is STAA forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
5.7%
Industry
7.79%
Market
12.75%
STAA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STAA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STAA vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
STAA$24.54$28.86+17.59%Buy
AZTA$39.06$36.00-7.83%Buy
KMTS$29.69$32.00+7.78%Strong Buy
AVR$6.31$12.50+98.10%Buy
LMAT$80.94$113.67+40.43%Buy
View Top Medical Stocks

Staar Surgical Co Stock Forecast FAQ

Is Staar Surgical Co Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: STAA) stock is to Buy STAA stock.

Out of 7 analysts, 3 (42.86%) are recommending STAA as a Strong Buy, 1 (14.29%) are recommending STAA as a Buy, 2 (28.57%) are recommending STAA as a Hold, 0 (0%) are recommending STAA as a Sell, and 1 (14.29%) are recommending STAA as a Strong Sell.

If you're new to stock investing, here's how to buy Staar Surgical Co stock.

What is STAA's earnings growth forecast for 2026-2028?

(NASDAQ: STAA) Staar Surgical Co's forecast annual earnings growth rate of 106.82% is forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 28.41%, and it is also forecast to beat the US market's average forecast earnings growth rate of 32.44%.

Staar Surgical Co's earnings in 2026 is $3,839,000.On average, 12 Wall Street analysts forecast STAA's earnings for 2026 to be $14,095,474, with the lowest STAA earnings forecast at $9,336,810, and the highest STAA earnings forecast at $25,272,568. On average, 12 Wall Street analysts forecast STAA's earnings for 2027 to be $28,246,106, with the lowest STAA earnings forecast at $21,622,086, and the highest STAA earnings forecast at $37,908,852.

In 2028, STAA is forecast to generate $33,691,743 in earnings, with the lowest earnings forecast at $22,113,497 and the highest earnings forecast at $42,647,458.

What is STAA's revenue growth forecast for 2026-2028?

(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 5.7% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.61%.

Staar Surgical Co's revenue in 2026 is $339,590,000.On average, 12 Wall Street analysts forecast STAA's revenue for 2026 to be $17,098,095,664, with the lowest STAA revenue forecast at $15,995,429,456, and the highest STAA revenue forecast at $18,248,900,097. On average, 12 Wall Street analysts forecast STAA's revenue for 2027 to be $18,587,371,989, with the lowest STAA revenue forecast at $17,164,285,723, and the highest STAA revenue forecast at $20,255,160,897.

In 2028, STAA is forecast to generate $20,115,259,182 in revenue, with the lowest revenue forecast at $18,119,528,618 and the highest revenue forecast at $22,576,827,356.

What is STAA's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: STAA) forecast ROA is 14.53%, which is lower than the forecast US Medical Instruments & Supplies industry average of 17.98%.

What is STAA's Price Target?

According to 7 Wall Street analysts that have issued a 1 year STAA price target, the average STAA price target is $28.86, with the highest STAA stock price forecast at $37.00 and the lowest STAA stock price forecast at $19.00.

On average, Wall Street analysts predict that Staar Surgical Co's share price could reach $28.86 by Sep 29, 2027. The average Staar Surgical Co stock price prediction forecasts a potential upside of 17.59% from the current STAA share price of $24.54.

What is STAA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: STAA) Staar Surgical Co's current Earnings Per Share (EPS) is $0.08. On average, analysts forecast that STAA's EPS will be $0.28 for 2026, with the lowest EPS forecast at $0.19, and the highest EPS forecast at $0.50. On average, analysts forecast that STAA's EPS will be $0.56 for 2027, with the lowest EPS forecast at $0.43, and the highest EPS forecast at $0.76. In 2028, STAA's EPS is forecast to hit $0.67 (min: $0.44, max: $0.85).

What is STAA's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: STAA) forecast ROE is 18.9%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.